+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Automated Immunoassay Analyzers Market by Product, Application, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5887279
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Automated Immunoassay Analyzers Market grew from USD 11.82 billion in 2023 to USD 12.63 billion in 2024. It is expected to continue growing at a CAGR of 6.92%, reaching USD 18.89 billion by 2030.

Automated Immunoassay Analyzers are advanced medical devices used to conduct tests on blood or fluid samples to detect and quantify specific proteins or antibodies, playing a crucial role in diagnostics and healthcare research. The necessity of these analyzers stems from the growing demand for fast, reliable, and high-throughput diagnostics in clinical laboratories, driven by increasing incidences of infectious diseases, cancers, and autoimmune disorders. Their applications span various sectors such as hospitals, laboratories, and pharmaceutical and biotech firms, with end-use scope extending to clinical diagnostics, drug development, and veterinary medicine. The market for automated immunoassay analyzers is being fueled by technological advancements like enhanced automation, reduction in human intervention, and improved data accuracy and review processes. Key growth influences include an aging population with rising healthcare needs, increased healthcare R&D spending, and the global push towards personalized medicine. Recent opportunities lie in the expansion of point-of-care testing, development of biopharmaceuticals, and growing awareness in emerging markets. Companies can capitalize on these opportunities by investing in next-gen analyzers with integrated AI and machine learning for predictive analytics. However, market dynamics are not devoid of challenges; high equipment costs, stringent regulatory environments, and the need for skilled personnel are significant limitations
that could hinder growth. Innovation and research areas ripe for exploration include miniaturization of equipment, multiplex testing capabilities, and incorporation of IoT for seamless data integration and remote diagnostics. The market is competitive yet poised for growth thanks to continuous technological advancements and increasing partnerships and collaborations. Companies seeking to grow must understand these complex market dynamics, invest in emerging technologies, and focus on user education and training while navigating regulatory challenges. This will not only enhance operational efficiency but also offer a strategic edge in a dynamic and evolving healthcare landscape.

Understanding Market Dynamics in the Automated Immunoassay Analyzers Market

The Automated Immunoassay Analyzers Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing prevalence of chronic and infectious diseases across the globe
    • Rapid shift towards clinical laboratory automation
    • Surging awareness of early diagnosis and treatments
  • Market Restraints
    • Associated high cost of automated immunoassay analyzers and budget constraints
  • Market Opportunities
    • Integration of novel technologies in automated immunoassay analyzers
    • Emergence of advanced immunoassay analyzer for enhanced laboratory performance
  • Market Challenges
    • Lack of trained and experienced professionals

Exploring Porter’s Five Forces for the Automated Immunoassay Analyzers Market

Porter’s Five Forces framework further strengthens the insights of the Automated Immunoassay Analyzers Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Automated Immunoassay Analyzers Market

External macro-environmental factors deeply influence the performance of the Automated Immunoassay Analyzers Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Automated Immunoassay Analyzers Market

The Automated Immunoassay Analyzers Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Automated Immunoassay Analyzers Market

The Automated Immunoassay Analyzers Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Automated Immunoassay Analyzers Market

The Automated Immunoassay Analyzers Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Automated Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arlington Scientific, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biobase Biodusty(Shandong), Co., Ltd., bioMérieux SA, Carolina Liquid Chemistries Corp., Charles River Laboratories, Chengdu Vacure Biotechnology Co., Ltd., Danaher Corporation, F. Hoffmann-La Roche AG, Getein Biotech, Inc., Hipro Biotechnology Co., Ltd., Hitachi, Ltd., Illumina, Inc., Laboratory Corporation of America Holdings, Luminex Corporation by DiaSorin Company, Medline Industries, LP, Meril Life Sciences Pvt. Ltd., PerkinElmer, Inc., PHC Europe B.V., Qiagen N.V., Randox Laboratories, Siemens Healthineers, and Sysmex Corporation.

Market Segmentation & Coverage

This research report categorizes the Automated Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Chemiluminescence
    • Enzyme-Linked Fluorescent System
    • Immunofluorescence
    • Radioimmunoassay
  • Application
    • Allergy Testing
    • Chronic Diseases
    • Drug Monitoring
    • Endocrinology
    • Infectious Diseases
  • End-User
    • Academic Research Institutes
    • Biotech & Pharma Companies
    • Diagnostic Test Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of chronic and infectious diseases across the globe
5.1.1.2. Rapid shift towards clinical laboratory automation
5.1.1.3. Surging awareness of early diagnosis and treatments
5.1.2. Restraints
5.1.2.1. Associated high cost of automated immunoassay analyzers and budget constraints
5.1.3. Opportunities
5.1.3.1. Integration of novel technologies in automated immunoassay analyzers
5.1.3.2. Emergence of advanced immunoassay analyzer for enhanced laboratory performance
5.1.4. Challenges
5.1.4.1. Lack of trained and experienced professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Automated Immunoassay Analyzers Market, by Product
6.1. Introduction
6.2. Chemiluminescence
6.3. Enzyme-Linked Fluorescent System
6.4. Immunofluorescence
6.5. Radioimmunoassay
7. Automated Immunoassay Analyzers Market, by Application
7.1. Introduction
7.2. Allergy Testing
7.3. Chronic Diseases
7.4. Drug Monitoring
7.5. Endocrinology
7.6. Infectious Diseases
8. Automated Immunoassay Analyzers Market, by End-User
8.1. Introduction
8.2. Academic Research Institutes
8.3. Biotech & Pharma Companies
8.4. Diagnostic Test Laboratories
8.5. Hospitals
9. Americas Automated Immunoassay Analyzers Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Automated Immunoassay Analyzers Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Automated Immunoassay Analyzers Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
FIGURE 2. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AUTOMATED IMMUNOASSAY ANALYZERS MARKET DYNAMICS
TABLE 7. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED FLUORESCENT SYSTEM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ALLERGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY BIOTECH & PHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY DIAGNOSTIC TEST LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. CANADA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. MEXICO AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. CHINA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. INDIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. JAPAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. THAILAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. DENMARK AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. EGYPT AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. FINLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. FRANCE AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 101. GERMANY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. ITALY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. NORWAY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. POLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. QATAR AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SPAIN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. TURKEY AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM AUTOMATED IMMUNOASSAY ANALYZERS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. AUTOMATED IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 151. AUTOMATED IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Automated Immunoassay Analyzers market, which are profiled in this report, include:
  • Abbott Laboratories
  • Arlington Scientific, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biobase Biodusty(Shandong), Co., Ltd.
  • bioMérieux SA
  • Carolina Liquid Chemistries Corp.
  • Charles River Laboratories
  • Chengdu Vacure Biotechnology Co., Ltd.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Getein Biotech, Inc.
  • Hipro Biotechnology Co., Ltd.
  • Hitachi, Ltd.
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings
  • Luminex Corporation by DiaSorin Company
  • Medline Industries, LP
  • Meril Life Sciences Pvt. Ltd.
  • PerkinElmer, Inc.
  • PHC Europe B.V.
  • Qiagen N.V.
  • Randox Laboratories
  • Siemens Healthineers
  • Sysmex Corporation

Methodology

Loading
LOADING...

Table Information